OSIRIS THERAPEUTICS, INC. 4
4 · OSIRIS THERAPEUTICS, INC. · Filed Jan 21, 2014
Insider Transaction Report
Form 4
FRIEDLI PETER
Director10% OwnerOther
Transactions
- Other
Common Stock
2014-01-17+0→ 4,606,051 total(indirect: See Notes 1 and 2)
Holdings
- 10,194,404
Common Stock
Footnotes (2)
- [F1]The Reporting Person previously reported an indirect beneficial interest in 4,103,301 shares of common stock held by Venturetec, Inc., 500,000 shares held by his minor daughter and 2,750 shares held by his spouse. The Reporting Person holds approximately 2% interest in the parent of Venturetec, Inc. and serves as president of Venturetec, Inc.
- [F2]On January 17, 2014, the Reporting Person purchased a convertible bond for a purchase price of $13,200,000, which entitles him to acquire approximately 19% additional interest in Venturetec, Inc. This Form 4 is being filed to reflect that purchase to the extent of any corresponding increase in the pecuniary interest of the Reporting Person in the shares held by Venturetec, Inc. The Reporting Person previously reported beneficial ownership of all shares of common stock held by Venturetec, Inc. and therefor there is no change in the number of shares reported in Table 1 above. The Reporting Person disclaims beneficial interest in the shares held by his daughter and spouse, and disclaims beneficial interest in the shares held by Venturetec, Inc., including beyond the extent of his pecuniary interest therein.